Document Detail


The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancer.
MedLine Citation:
PMID:  16024247     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Intratumoral aromatase is a therapeutic target for the treatment of post-menopausal estrogen-dependent breast cancers. Therefore, reliable methods should be developed for routine application for the detection of intratumoral aromatase. Immunohistochemistry (IHC) is considered one of the most suitable methods in this regard. A multi-centre collaborative group has been established to generate and validate new aromatase monoclonal antibodies. We have selected two monoclonal antibodies, #677 against native aromatase protein and F2 against formalin-fixed protein for this purpose. With these two monoclonal antibodies 43 cases of invasive ductal carcinoma, which had been previously assayed for aromatase activity by product isolation methodology, were immunostained in three laboratories in UK, USA and Japan and independently evaluated by three pathologists (H.S., T.A. and S.G.S.). Staining of malignant epithelium, adipose tissue, normal/benign and stromal compartments of the tumors were assessed by estimating the proportion of positive staining cells and the relative intensity of staining in this fashion. Immunoreactivity could be detected in each component of the tissue specimens but a significant positive correlation with biochemical activity was detected only in malignant epithelium stained with 677 not in other components with #677 and not in any of the components. Staining using F2 as a primary antibody did not produce a positive correlation in any components with aromatase activity. These results suggest that we now have a monoclonal antibody against aromatase (#677) which may be used to stain archival materials. A methodology and scoring system is recommended whereby staining significantly correlates with aromatase activity of the resected tissue specimens of breast cancer.
Authors:
H Sasano; T J Anderson; S G Silverberg; R J Santen; M Conway; D P Edwards; A Krause; A S Bhatnagar; D B Evans; W R Miller
Related Documents :
21345677 - The role of breast cancer civil society in different resource settings.
17694547 - Development of anaplastic lymphoma kinase (alk) small-molecule inhibitors for cancer th...
15335267 - Epidermal growth factor receptor status in breast cancer metastases to the central nerv...
17624587 - The role of cyclooxygenase-2 in breast cancer: review.
21934177 - False-negative tests in breast cancer management.
22698907 - Unilateral orbital pain and eyelid swelling in a 46-year-old woman: orbital metastasis ...
Publication Detail:
Type:  Journal Article; Validation Studies    
Journal Detail:
Title:  The Journal of steroid biochemistry and molecular biology     Volume:  95     ISSN:  0960-0760     ISO Abbreviation:  J. Steroid Biochem. Mol. Biol.     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-08-08     Completed Date:  2005-09-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9015483     Medline TA:  J Steroid Biochem Mol Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  35-9     Citation Subset:  IM    
Affiliation:
Department of Pathology, Tohoku University School of Medicine, 2-1 Seiryou-machi, Sendai 980-8575, Japan. hsasano@patholo2.med.tohoku.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal*
Aromatase / analysis*,  immunology
Breast Neoplasms / diagnosis,  enzymology*
Female
Humans
Immunohistochemistry*
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; EC 1.14.14.1/Aromatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer.
Next Document:  Aromatase in endometriosis and uterine leiomyomata.